Galectin Therapeutics (GALT) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.43% |
| Dec 31, 2025 | -53.75% |
| Sep 30, 2025 | 16.31% |
| Jun 30, 2025 | -85.32% |
| Sep 30, 2024 | -5.71% |
| Jun 30, 2024 | -8.67% |
| Mar 31, 2024 | 8.20% |
| Dec 31, 2023 | -26.02% |
| Sep 30, 2023 | -13.34% |
| Jun 30, 2023 | -0.94% |
| Sep 30, 2022 | 34.52% |
| Jun 30, 2022 | 23.50% |
| Sep 30, 2021 | -15.83% |
| Jun 30, 2021 | -52.21% |
| Mar 31, 2021 | 23.51% |
| Dec 31, 2020 | 16.63% |
| Sep 30, 2020 | 20.14% |
| Jun 30, 2020 | 5.91% |
| Mar 31, 2020 | 8.74% |
| Dec 31, 2019 | 5.68% |
| Sep 30, 2019 | 3.28% |
| Jun 30, 2019 | -646.46% |
| Mar 31, 2019 | 15.52% |
| Dec 31, 2018 | 18.58% |
| Sep 30, 2018 | 3.44% |
| Jun 30, 2018 | -163.21% |
| Mar 31, 2018 | -30.63% |
| Dec 31, 2017 | 56.12% |
| Sep 30, 2017 | 23.76% |
| Jun 30, 2017 | 33.11% |
| Mar 31, 2017 | 11.18% |
| Dec 31, 2016 | -7.16% |
| Sep 30, 2016 | 11.76% |
| Jun 30, 2016 | 21.15% |
| Mar 31, 2016 | 14.50% |
| Dec 31, 2015 | -13.04% |
| Sep 30, 2015 | 19.13% |
| Jun 30, 2015 | 10.18% |
| Mar 31, 2015 | -0.76% |
| Dec 31, 2014 | 6.64% |
| Sep 30, 2014 | 9.36% |
| Jun 30, 2014 | 5.93% |
| Mar 31, 2014 | -248.88% |
| Dec 31, 2013 | -7.97% |
| Sep 30, 2013 | -90.53% |
| Jun 30, 2013 | 27.34% |
| Mar 31, 2013 | 25.05% |
| Dec 31, 2012 | 15.33% |
| Sep 30, 2012 | 15.77% |
| Jun 30, 2012 | -4.42% |
| Mar 31, 2012 | -196.35% |
| Dec 31, 2011 | 20.09% |
| Sep 30, 2011 | 8.15% |
| Jun 30, 2011 | 16.80% |
| Mar 31, 2011 | -64.37% |
| Dec 31, 2010 | -50.21% |
| Sep 30, 2010 | 1.71% |